Skip to main content
. 2020 Jan 24;6(1):34–40. doi: 10.1016/j.wjorl.2019.05.001

Table 1.

Comparison of baseline information.

group Cases (n) Gender (M/F) Stage
StageⅡ StageⅢ StageⅣa StageⅣb
Resistant group 36 28/9 17 11 6 2
Sensitive group 21 17/3 13 5 2 1
χ2 value 0.679 0.426 −0.728
P value >0.05 >0.05 >0.05